StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30119% above fair value
$3.95−0.12 (-2.95%)

Close on Nov 19, 2026Market cap $1.27BP/E –Yield –

MannKind free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

MannKind's free cash flow for the twelve months ending Jun 30, 2026 was -$18.14M, down 163.0% year over year. For fiscal 2025 it was $13.69M, down 58.3% from the year before. The highest annual figure on record is $32.82M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.69M-58.3%
FY2024Dec 31, 2024$32.82M–
FY2023Dec 31, 2023-$8.35M–
FY2022Dec 31, 2022-$88.27M–
FY2021Dec 31, 2021-$73.18M–
FY2020Dec 31, 2020-$28.93M–
FY2019Dec 31, 2019-$91.05M–
FY2018Dec 31, 2018-$38.09M–
FY2016Dec 31, 2016-$79.23M–
FY2015Dec 31, 2015-$67.52M–
FY2014Dec 31, 2014-$20.01M–
FY2013Dec 31, 2013-$136.72M–
FY2012Dec 31, 2012-$120.50M–
FY2011Dec 31, 2011-$130.70M–
FY2010Dec 31, 2010-$158.20M–
FY2009Dec 31, 2009-$202.94M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$23.45M-399.4%
Q1 FY2026Mar 31, 2026-$7.25M–
Q4 FY2025Dec 31, 2025-$9.95M-150.4%
Q3 FY2025Sep 30, 2025$22.52M+184.5%
Q2 FY2025Jun 30, 2025$7.83M+809.8%
Q1 FY2025Mar 31, 2025-$6.71M-256.2%
Q4 FY2024Dec 31, 2024$19.75M+25.0%
Q3 FY2024Sep 30, 2024$7.91M–
Q2 FY2024Jun 30, 2024$861.00K–
Q1 FY2024Mar 31, 2024$4.30M–
Q4 FY2023Dec 31, 2023$15.80M–
Q3 FY2023Sep 30, 2023-$2.72M–
Q2 FY2023Jun 30, 2023-$14.27M–
Q1 FY2023Mar 31, 2023-$7.16M–
Q4 FY2022Dec 31, 2022-$7.47M–
Q3 FY2022Sep 30, 2022-$28.34M–
Q2 FY2022Jun 30, 2022-$29.15M–
Q1 FY2022Mar 31, 2022-$23.30M–
Q4 FY2021Dec 31, 2021-$17.54M–
Q3 FY2021Sep 30, 2021-$19.43M–
Q2 FY2021Jun 30, 2021-$22.50M–
Q1 FY2021Mar 31, 2021-$13.71M–
Q4 FY2020Dec 31, 2020-$262.00K–
Q3 FY2020Sep 30, 2020-$13.46M–
Q2 FY2020Jun 30, 2020-$3.83M–
Q1 FY2020Mar 31, 2020-$11.37M–
Q4 FY2019Dec 31, 2019-$5.22M–
Q3 FY2019Sep 30, 2019-$53.01M–
Q2 FY2019Jun 30, 2019-$20.95M–
Q1 FY2019Mar 31, 2019-$11.87M–
Q4 FY2016Dec 31, 2016-$12.75M–
Q3 FY2016Sep 30, 2016-$23.07M–

More MannKind figures

See a number that looks wrong?